Cervical cancer is the fourth most common cancer among women globally. The burden
faced by low-and middle-income countries is significantly greater than high-income …

Background Human papillomavirus (HPV) vaccination programmes were first implemented
in several countries worldwide in 2007. We did a systematic review and meta-analysis to …

Background Since 2006, many countries have implemented publicly funded human
papillomavirus (HPV) immunisation programmes. However, global estimates of the extent …

Infection with human papillomavirus (HPV) is recognized as one of the major causes of
infection-related cancer worldwide, as well as the causal factor in other diseases. Strong …

End of study analyses of the phase III trials of prophylactic human papillomavirus (HPV)
virus-like particle (VLP) vaccines in young women are now largely completed. Two distinct …

Background: Noncommunicable diseases, and especially cancers, are recognized as an
increasing problem for low and middle income countries. Effective control programs require …

Purpose The global incidence of oropharyngeal squamous cell carcinoma (OPSCC) has
been increasing, and it has been proposed that a rising rate of human papillomavirus (HPV) …

Background: The purpose of this review was to explore the uptake of the human
papillomavirus (HPV) vaccination, its associated factors, and the facilitators of and barriers to …

Background Australia was one of the first countries to introduce a publicly funded national
human papillomavirus (HPV) vaccination program that commenced in April 2007, using the …

Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …